We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

138 hedge funds and large institutions have $417M invested in VanEck Pharmaceutical ETF in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

227% more call options, than puts

Call options by funds: $1.63M | Put options by funds: $499K

25% more funds holding

Funds holding: 110 → 138 (+28)

15% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 34

6% more capital invested

Capital invested by funds: $394M → $417M (+$23.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11.47% less ownership

Funds ownership: 88.94% → 77.47% (-11%)

Holders
138
Holders Change
+28
Holders Change %
+25.45%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
39
Reduced
34
Closed
9
Calls
$1.63M
Puts
$499K
Net Calls
+$1.13M
Net Calls Change
+$4.11M

Top Buyers

Rank Fund Capital Flow
1
JSAM
J. Safra Asset Management
New York
+$6.09M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.58M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.27M
4
BHB
Bank Hapoalim BM
Israel
+$3.09M
5
Jane Street
Jane Street
New York
+$3.05M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$19M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$8.76M
3
VV
Verity & Verity
South Carolina
-$7.77M
4
Morgan Stanley
Morgan Stanley
New York
-$6.41M
5
VAS
Valicenti Advisory Services
New York
-$4.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
126
Highlander Capital Management
New Jersey
$12.7K – – –
CWM
127
CarsonAllaria Wealth Management
Illinois
$12.1K +$11.6K +133 New
IGWM
128
ICA Group Wealth Management
Colorado
$9.52K -$2.71K -31 -23%
BBPWM
129
Blue Bell Private Wealth Management
Pennsylvania
$7.08K – – –
PCM
130
Penserra Capital Management
California
$7K +$7.36K +84 New
MIM
131
Macroview Investment Management
Maryland
$5.8K – – –
AIM
132
Anchor Investment Management
South Carolina
$5.26K – – –
DJSG
133
D.J. St. Germain
Massachusetts
$4.54K – – –
SWA
134
SOA Wealth Advisors
New York
$3.09K – – –
VanEck Associates
135
VanEck Associates
New York
$3K -$2.98K -34 -53%
RIA
136
Realta Investment Advisors
Delaware
$728 +$700 +8 New
HIA
137
Harbor Investment Advisory
Maryland
$191 – – –
GFPC
138
Global Financial Private Client
Florida
$89 – – –
HNB
139
Huntington National Bank
Ohio
$78 – – –
VV
140
Verity & Verity
South Carolina
– -$7.77M -95,555 Closed
HF
141
HRT Financial
New York
– -$3.78M -46,430 Closed
TI
142
Trexquant Investment
Connecticut
– -$504K -6,195 Closed
PCS
143
Private Client Services
Kentucky
– -$298K -3,667 Closed
CIAS
144
Capital Investment Advisory Services
North Carolina
– -$38.6K -475 Closed
WTG
145
West Tower Group
Virginia
– -$33.3K -409 Closed
ASN
146
Advisory Services Network
Georgia
– -$8.95K -110 Closed
CG
147
Cutler Group
California
– -$8K -100 Closed
TFGT
148
TS Financial Group (TSFG)
Illinois
– -$4K -50 Closed
2 3 4 5
6

PPH Hedge Fund Activity: Q1 2024 in Review

138 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q1 2024, worth a combined $417M — up 5.9% from $394M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PPH positions and 9 closed out — a net gain of 29 holders — while 39 added to existing stakes and 34 trimmed.

The largest buyer was J. Safra Asset Management, opening a new position worth an estimated $6.09M. The largest seller was Bank of America, cutting an estimated $19M.

  • 138 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q1 2024, up from 110 in Q4 2023.
  • Funds reported $417M of VanEck Pharmaceutical ETF stock for Q1 2024, up 5.9% quarter-over-quarter.
  • 38 funds opened new VanEck Pharmaceutical ETF positions in Q1 2024 and 9 closed out, a net change of +29 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q1 2024 was J. Safra Asset Management, an estimated $6.09M added.
  • The largest VanEck Pharmaceutical ETF seller in Q1 2024 was Bank of America, an estimated $19M sold.

Based on aggregated 13F filings for Q1 2024.